SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001347613-18-000027
Filing Date
2018-08-08
Accepted
2018-08-08 13:12:47
Documents
62
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sgyp-20180630.htm   iXBRL 10-Q 859870
2 EX 31.1 sgyp-ex311x63018x10q.htm EX-31.1 14278
3 EX 31.2 sgyp-ex312x63018x10q.htm EX-31.2 14350
4 EX 32.1 sgyp-ex321x63018x10q.htm EX-32.1 7665
5 EX 32.2 sgyp-ex322x63018x10q.htm EX-32.2 8225
  Complete submission text file 0001347613-18-000027.txt   4756665

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20180630.xsd EX-101.SCH 36450
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20180630_cal.xml EX-101.CAL 60860
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20180630_def.xml EX-101.DEF 226050
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgyp-20180630_lab.xml EX-101.LAB 470115
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20180630_pre.xml EX-101.PRE 325263
11 EXTRACTED XBRL INSTANCE DOCUMENT sgyp-20180630_htm.xml XML 730818
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35268 | Film No.: 181000646
SIC: 2834 Pharmaceutical Preparations